LEMBOREXANT vs LERCANIDIPINE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LEMBOREXANT vs LERCANIDIPINE: Safety Overview
| Metric | LEMBOREXANT | LERCANIDIPINE |
|---|---|---|
| Total FAERS Reports | 989 | 3,767 |
| Deaths Reported | 44 | 248 |
| Death Rate | 4.4% | 6.6% |
| Hospitalizations | 278 | 2,249 |
| Average Patient Age | 58.9 yrs | 65.8 yrs |
| % Female Patients | 63.4% | 47.8% |
| FDA Approval Date | Apr 7, 2020 | N/A |
| Manufacturer | Eisai Inc. | N/A |
| Route | ORAL | N/A |
| Marketing Status | Prescription | N/A |